The first Novapen and the latest Novapen 6
Novopen® introduced in 1985 was the first insulin pen ever produced.
Since then Novo pens had its successful journey with tremendous improvements
to the pen at each stage from the first Novopen® to NovoPen® 3 , NovoPen®
4 , NovoPen Echo®, NovoPen® 5 and now the latest in this series the NovoPen 6.
NovoPen Echo®, an insulin pen specifically designed to meet the needs of children
with diabetes and is the first ever insulin pen to offer a combination of a memory
function with a half-unit dosing option.
The most latest in this series is the NovoPen 6 and NovoPen Echo Plus which are
reusable insulin pens equipped with NFC (Near Field Communication) technology by
which they can be scanned in close proximity to move the data off the pen and to
another device. The pens have an 800-injection dose memory and a remarkable
five-year battery life. No recharging is necessary which can be quoted as an
advantage of using NFC. The NovoPen 6 and NovoPen Echo Plus both feature an electronic
display that shows the amount of active insulin (insulin on board or “IOB”),
size of the last dose, and time since last injection.
Beyond reusable pens, Novo Nordisk also announced that connectivity for disposable
pens and the feature will capture insulin doses through a Bluetooth-enabled smart
device that is attached to the widely used disposable FlexTouch pen. The attachment
will transmit the insulin dose, time of dose, and the type of insulin being injected
to a phone app..